Related Experiment Video
Updated: Jan 28, 2026

Electrochemotherapy of Tumours
Published on: December 15, 2008
Rosette-forming glioneuronal tumour of the fourth ventricle. Not always a foreseeable development
Aida Antuña Ramos1, Ivan Fernandez Vega2, Kelvin Piña Batista1
1Department of Neurosurgery, Central University Hospital of Asturias, Oviedo, Spain.
Aim Of The Study:
Rosette-forming glioneuronal tumour (RGNT) of the fourth ventricle is an uncommon tumour. The management is not consensual. Most of the published cases show stable outcome with and without gross total resection and are regarded as having a relatively indolent behaviour.
Material And Methods:
We present a 32-year-old man with a tumour in the fourth ventricle. He underwent midline suboccipital craniectomy with gross total removal.
Results:
The histopathological diagnosis was RGNT grade I. Four years later he presented a radiological progression and received stereotactic radiosurgery. At the last follow-up seven years after surgery, the MRI showed no recurrence.
Conclusions:
RGNT should be considered in the differential diagnosis of a posterior fossa tumour and has to be differentiated from other lesions for its indolent course and favourable prognosis. Surgical procedures should be carefully performed to avoid serious surgical morbidities. Stereotactic radiosurgery treatment appears to be a useful treatment in recurrence episodes.
Related Concept Videos
Anatomy of the Brain: Ventricles
Discharge Summary Forms
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Production of Formed Elements
Most HSCs commit to...
Cartesian Form for Vector Formulation
Indeterminate Forms and L’Hôpital’s Rule
Differential Form of Maxwell's Equations

